Allogeneic Bone Impregnated with Biodegradable Depot Delivery Systems for the Local Treatment of Joint Replacement Infections: An In Vitro Study.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
01 Oct 2022
Historique:
received: 01 09 2022
revised: 21 09 2022
accepted: 27 09 2022
entrez: 14 10 2022
pubmed: 15 10 2022
medline: 18 10 2022
Statut: epublish

Résumé

Although progress is evident in the effective treatment of joint replacement-related infections, it still remains a serious issue in orthopedics. As an example, the local application of antibiotics-impregnated bone grafts supplies the high drug levels without systemic side effects. However, antibiotics in the powder or solution form could be a risk for local toxicity and do not allow sustained drug release. The present study evaluated the use of an antibiotic gel, a water-in-oil emulsion, and a PLGA microparticulate solid dispersion as depot delivery systems impregnating bone grafts for the treatment of joint replacement-related infections. The results of rheological and bioadhesive tests revealed the suitability of these formulations for the impregnation of bone grafts. Moreover, no negative effect on proliferation and viability of bone marrow mesenchymal stem cells was detected. An ex vivo dissolution test of vancomycin hydrochloride and gentamicin sulphate from the impregnated bone grafts showed a reduced burst and prolonged drug release. The PLGA-based formulation proved to be particularly promising, as one-day burst release drugs was only 15% followed with sustained antibiotics release with zero-order kinetics. The results of this study will be the basis for the development of a new product in the Tissue Section of the University Hospital for the treatment of bone defects and infections of joint replacements.

Identifiants

pubmed: 36235024
pii: molecules27196487
doi: 10.3390/molecules27196487
pmc: PMC9571001
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Emulsions 0
Gentamicins 0
Powders 0
Water 059QF0KO0R
Vancomycin 6Q205EH1VU

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : MEYS CZ
ID : SVV 260 547
Organisme : MEYS CZ
ID : Cooperatio Program (research areas SURG and PharmSci)
Organisme : GAUK
ID : 164122/2022
Organisme : MHCZ - DRO
ID : UHHK, 00179906

Références

J Control Release. 2019 Jul 28;306:97-107
pubmed: 31150749
Molecules. 2020 Apr 30;25(9):
pubmed: 32365923
J Bone Jt Infect. 2019 Oct 15;4(5):245-253
pubmed: 31700774
Front Microbiol. 2020 Jan 17;10:2935
pubmed: 32010069
J Control Release. 2020 Aug 10;324:695-727
pubmed: 32479845
Int J Mol Sci. 2020 Dec 04;21(23):
pubmed: 33291550
Cell Tissue Bank. 2006;7(4):319-23
pubmed: 16710632
BMC Musculoskelet Disord. 2017 Sep 2;18(1):381
pubmed: 28865450
Blood. 2001 Nov 1;98(9):2615-25
pubmed: 11675329
Acta Biomater. 2021 Jun;127:56-79
pubmed: 33831569
Folia Microbiol (Praha). 2020 Jun;65(3):475-482
pubmed: 31654320
Drugs. 2000 Jun;59(6):1223-32
pubmed: 10882159
Adv Drug Deliv Rev. 2001 Jun 11;48(2-3):139-57
pubmed: 11369079
Nanomaterials (Basel). 2021 Mar 16;11(3):
pubmed: 33809764
J Orthop Traumatol. 2021 Nov 9;22(1):44
pubmed: 34751836
Eur J Pharm Sci. 2021 Aug 1;163:105855
pubmed: 33872699
Injury. 2006 May;37 Suppl 2:S95-104
pubmed: 16651078
J Antimicrob Chemother. 2000 Sep;46(3):423-8
pubmed: 10980169
Int J Pharm. 2022 Mar 5;615:121474
pubmed: 35041918
J Bone Joint Surg Br. 2011 Feb;93(2):151-7
pubmed: 21282751
Nat Commun. 2013;4:1724
pubmed: 23591891
Acta Pharm. 2020 Mar 1;70(1):63-75
pubmed: 31677370
Int J Pharm. 2013 Dec 31;458(2):282-6
pubmed: 24183958
Eur J Pharm Sci. 2008 Aug 7;34(4-5):226-35
pubmed: 18513929
Compr Rev Food Sci Food Saf. 2019 Nov;18(6):1660-1675
pubmed: 33336953
Int J Biomater. 2012;2012:538061
pubmed: 22899933
Eur J Pharm Biopharm. 2019 Sep;142:498-505
pubmed: 31330258
J Orthop Trauma. 2014 Jun;28(6):370-5
pubmed: 23948961
Clin Orthop Relat Res. 2005 Aug;(437):105-10
pubmed: 16056034
Int Orthop. 2010 Feb;34(1):137-42
pubmed: 19205701
Adv Healthc Mater. 2018 Jan;7(1):
pubmed: 29171928
Adv Colloid Interface Sci. 2018 Jan;251:55-79
pubmed: 29248154
J Orthop Trauma. 2020 May;34(5):231-237
pubmed: 32304564
Front Pharmacol. 2016 Jun 28;7:185
pubmed: 27445821
Int J Pharm. 2001 Mar 14;215(1-2):13-27
pubmed: 11250088
Lancet. 2016 Jan 23;387(10016):386-394
pubmed: 26135702
J Long Term Eff Med Implants. 2005;15(6):629-39
pubmed: 16393131

Auteurs

Libor Prokes (L)

Department of Orthopaedic Surgery, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic.
Faculty of Medicine, Charles University, Simkova 870, 500 03 Hradec Kralove, Czech Republic.

Eva Snejdrova (E)

Department of Pharmaceutical Technology, Faculty of Pharmacy, Charles University, Akademika Heyrovskeho 1203, 500 05 Hradec Kralova, Czech Republic.

Tomas Soukup (T)

Department of Histology and Embryology, Faculty of Medicine, Charles University, Simkova 870, 500 03 Hradec Kralove, Czech Republic.

Jana Malakova (J)

Department of Clinical Biochemistry and Diagnostics, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic.

Vladislav Frolov (V)

Department of Pharmaceutical Technology, Faculty of Pharmacy, Charles University, Akademika Heyrovskeho 1203, 500 05 Hradec Kralova, Czech Republic.

Jan Loskot (J)

Department of Physics, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 500 03 Hradec Kralove, Czech Republic.

Rudolf Andrys (R)

Department of Chemistry, Faculty of Science, University of Hradec Kralove, Rokitanskeho 62, 500 03 Hradec Kralove, Czech Republic.

Tomas Kucera (T)

Department of Orthopaedic Surgery, University Hospital Hradec Kralove, Sokolska 581, 500 05 Hradec Kralove, Czech Republic.
Faculty of Medicine, Charles University, Simkova 870, 500 03 Hradec Kralove, Czech Republic.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH